Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ALPMF
Recent news which mentions ALPMF
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
October 05, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
ALPMF
Large Cap
News
From
Benzinga
Why Is Seagen Stock Trading Higher Today?
September 22, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
ALPMY
SGEN
MRK
From
Benzinga
What's Going On With Neurology Focused Taysha Gene Therapies Stock Today?
September 20, 2023
Tickers
ALPMF
ALPMY
TSHA
Tags
Health Care
Contracts
why it's moving
From
Benzinga
Why Shares of Adaptive Biotechnologies Jumped This Week
June 16, 2023
Tickers
ADPT
ALPMF
Tags
ALPMF
ADPT
Market News
From
Motley Fool
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
June 08, 2023
Tickers
ALPMF
ALPMY
Tags
gene therapy
Market News
Biotech
From
Benzinga
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
May 30, 2023
Tickers
ALPMF
ISEE
OKYO
VTRS
Tags
Market News
Partner Content
Penny Stocks
From
Benzinga
Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top Stories
May 15, 2023
Tickers
AAPL
ALPMF
ALPMY
BTI
Tags
NCMGY
ALPMF
Large Cap
From
Benzinga
Astellas' Menopause Drug Sores FDA Approval, After Regulatory Setback
May 15, 2023
Tickers
ALPMF
ALPMY
Tags
Health Care
Market News
Biotech
From
Benzinga
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
May 01, 2023
Tickers
ALPMF
ALPMY
PFE
Tags
Benzinga
ALPMY
General
From
Benzinga
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'
May 01, 2023
Tickers
ALPMF
ALPMY
ISEE
Tags
Health Care
why it's moving
M&A
From
Benzinga
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
April 04, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
MRK
Market News
Biotech
From
Benzinga
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
March 28, 2023
Tickers
ABBV
ALPMF
BMY
CTMX
Tags
Benzinga
Movers
General
From
Benzinga
Japanese Government Urges China To Release Astellas Pharma's Employee
March 27, 2023
Tickers
ALPMF
ALPMY
Tags
Legal
Market News
Biotech
From
Benzinga
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
March 17, 2023
Tickers
ALPMF
ALPMY
PFE
Tags
Health Care
Benzinga
General
From
Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
January 31, 2023
Tickers
ALPMF
ALPMY
HZNP
SELB
Tags
ALPMY
Analyst Color
Analyst Ratings
From
Benzinga
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
January 24, 2023
Tickers
ALPMF
ALPMY
GSK
NVS
Tags
ALPMF
Large Cap
News
From
Benzinga
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
October 25, 2022
Tickers
ALPMF
ALPMY
TSHA
Tags
Penny Stocks
Biotech
Market News
From
Benzinga
Astellas' Menopause Drug Under FDA Review
August 18, 2022
Tickers
ALPMF
ALPMY
Tags
General
FDA
Briefs
From
Benzinga
Seagen's Bladder Cancer Trial Data Meets Expectation, Analysts Say
July 26, 2022
Tickers
ALPMF
SGEN
Tags
Analyst Ratings
Biotech
Market News
From
Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
July 26, 2022
Tickers
ABBV
ALPMF
ANGN
BIIB
Tags
IBB
ABBV
NEOG
From
Benzinga
Seagen Shares Jump On Positive Data From Urothelial Cancer Trial
July 26, 2022
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
MRK
Biotech
Market News
From
Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
June 28, 2022
Tickers
ALPMF
CNTG
ELYM
EPIX
Tags
SPRO
IBB
Market News
From
Benzinga
Sutro Biopharma Stock Surges On Cancer Treatment Pact
June 28, 2022
Tickers
ALPMF
ALPMY
STRO
Tags
General
ALPMF
Briefs
From
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
AZN
General
FDA
From
Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
June 27, 2022
Tickers
ALPMF
ALPMY
Tags
News
Briefs
ALPMF
From
Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
May 09, 2022
Tickers
ALPMF
ALPMY
TWST
Tags
TWST
Small Cap
Biotech
From
Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
April 13, 2022
Tickers
ALPMF
ALPMY
SGEN
Tags
Health Care
Benzinga
News
From
Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
March 15, 2022
Tickers
ALPMF
ALPMY
Tags
Biotech
Market News
Health Care
From
Benzinga
Astellas Touts Safety Data For Phase 3 Menopause Drug, Sets Up US Filing
March 07, 2022
Tickers
ALPMF
ALPMY
Tags
Market News
Biotech
Health Care
From
Benzinga
Astellas Pharma - Seagen's Enfortumab Shows 36% Pathologic Complete Response In Bladder Cancer Patients
February 15, 2022
Tickers
ALPMF
ALPMY
SGEN
Tags
Health Care
bladder cancer
Briefs
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.